An interventional study of Virtual Reality Cognitive Stimulation Program in Cognitive Dysfunction and Mild Cognitive Impairment, sponsored by Badalona Serveis Assistencials. Completed at 1 site in Spain. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-06-11.
Sponsored by Badalona Serveis Assistencials · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 162 studies in Cognitive Dysfunction with a site in Spain — 44 open to participants now, 61 under way, 9 of them phase 3. Cognitive Dysfunction · Spain.
Among the 162 studies in Cognitive Dysfunction with a site in Spain, this one is the 102nd largest by enrollment of the 127 interventional ones that give a count, is one of 14 that started in 2023, is one of 91 with no phase, and was the 108th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →44 of the 162 studies in Cognitive Dysfunction with a site in Spain are open now. Recruiting first, the newest first:
Consorci Sanitari de l'Alt Penedès i Garraf · Sites in Spain
Ages 70+
Biogipuzkoa Health Research Institute · Sites in Spain
Ages 18+
Consorci Sanitari de Terrassa · Sites in Spain
Ages 65+ · Healthy volunteers
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Spain, Australia, Austria and 14 more countries
Ages 18+
Universidad Complutense de Madrid · Sites in Spain
Ages 65–85
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
162 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 19 · Phase 3 16 · Phase 4 3
First in 2004; this study’s year is marked. 14 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 45 is below the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 100 across the 127 interventional studies, 250 across the 35 observational. Of the 77 that completed or were terminated, 17 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 162 have an industry lead sponsor. The 10 most frequent:
Badalona Serveis Assistencials is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Badalona Serveis Assistencials has 2 studies filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
14 of the studies in Cognitive Dysfunction with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
| NCT07802392Consorci Sanitari de TerrassaImmersive Nature-Based Wellbeing Program in Older Adults With Cognitive Impairment | 2026-11 |
| NCT07793682Althaia Xarxa Assistencial Universitària de ManresaEarly Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke | 2026-11-25 |
| NCT06956794Consorci Sanitari de TerrassaMultimodal Training With Immersive Virtual Reality to Improve the Cognitive Health and Emotional Well-being of Older Women Living Alone | 2026-12-01 |
| NCT05289258Universidad de CórdobaUnified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments | 2026-12-30 |
Add all 14 to your calendar (.ics) → With an account.
Among the 162 studies in Cognitive Dysfunction with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to test a virtual reality (VR)-based program designed for cognitive stimulation in individuals attending the conventional cognitive rehabilitation program at the Day Hospital of CSSC (Centro Sociosanitario El Carme) in Badalona, Spain. The trial will specifically assess VR's impact on declarative memory and executive functions through interactive exercises, as well as attention and episodic memory through VR video stimuli.
The main questions it aims to answer are:
Participants will undergo a series of 8 sessions, scheduled twice a week to coincide with the conventional rehabilitation appointments. The VR equipment used will be Oculus Quest 2 headsets, offering an immersive experience with hand-tracking technology that simplifies interactions, particularly beneficial for those with mild cognitive impairment (MCI). During the study, participants will:
Researchers will analyze the data to see if:
Background:
Cognitive impairment affects a significant portion of the aging population, leading to challenges in daily functioning and a reduced quality of life. Traditional cognitive rehabilitation techniques have shown benefits, but patient engagement and adherence remain challenging. Innovations such as virtual reality (VR) offer new avenues for cognitive stimulation, potentially enhancing patient involvement and treatment outcomes.
Study Design:
This clinical trial aims to evaluate the acceptability and efficacy of a VR-based cognitive stimulation program among patients with mild to moderate cognitive impairment at Centro Sociosanitario El Carme in Badalona. It will employ a pretest-posttest design to assess cognitive changes, utilizing standardized cognitive scales and gathering qualitative feedback on user experience.
Objectives:
Primary Objective: To assess the acceptability of the VR-based cognitive stimulation program among patients with mild to moderate cognitive impairment.
Secondary Objectives:
To evaluate whether the VR interventions are perceived as engaging and motivating by the patients, which would suggest positive adherence to the cognitive stimulation program.
To measure changes in cognitive performance, particularly in attention and memory, pre- and post-intervention, to determine the effectiveness of the program.
To understand healthcare professionals' perceptions of the applicability of VR interventions in clinical practice for cognitive stimulation.
To identify potential improvements for the implementation of the VR program based on patient and healthcare staff feedback.
To gather data that could be useful for the development of future VR experiences aimed at patients with cognitive impairments.
Methodology:
Participants will be recruited from the Centro Sociosanitario El Carme and will undergo an initial assessment to establish a cognitive baseline. The participants will then engage in a series of VR sessions designed to provide cognitive stimulation. The program will focus on exercises to enhance attention and memory, incorporating interactive elements to maintain engagement. After completing the sessions, participants will be re-assessed using the same cognitive scales.
Feedback on the VR experience will be collected through structured interviews and questionnaires to gauge acceptability, perceived usefulness, and motivation. Healthcare professionals involved in the administration of the VR program will also be interviewed to understand their views on the integration of VR into therapeutic practices.
Expected Outcomes:
It is hypothesized that the VR program will be well-received by patients, evidenced by high rates of program completion and positive subjective feedback. Post-intervention improvements in cognitive scale scores are expected, indicating the potential efficacy of VR-based stimulation. Insights from healthcare professionals are anticipated to highlight the practicality of VR in clinical settings and suggest improvements for future applications.
Relevance:
The findings from this trial could support the adoption of VR technologies in cognitive rehabilitation, offering a novel, scalable, and potentially more effective approach to managing cognitive impairments. The study may also contribute to the evidence base required for integrating technological innovations into standard healthcare practice.
Conclusion:
By exploring the intersection of VR technology and cognitive rehabilitation, this study seeks to advance the understanding of innovative treatments for cognitive impairments and foster improved patient outcomes through enhanced engagement and stimulation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Withdrawal Criteria
The emergence of health problems that could interfere with the continuity of participation in the study, or the withdrawal of consent by the participant.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants with MCI undergo 8 VR sessions, using Oculus Quest 2 headsets for immersive cognitive exercises. Activities include a Supermarket Shopping Task for memory, a Payment Task for cognitive flexibility, and a Recipe Sequencing Task for problem-solving. Additionally, 360-degree videos with visuo-verbal stimulation are used to engage attention and episodic memory, monitored by therapists. The investigators employ Oculus Quest 2 VR headsets with hand tracking technology to provide a seamless and immersive experience, especially beneficial for participants with Mild Cognitive Impairment (MCI).
Device: Virtual Reality Cognitive Stimulation Program
Intervention Type: Device Intervention Name: Virtual Reality Cognitive Stimulation Program Description: This program utilizes virtual reality to conduct cognitive stimulation exercises aimed at improving memory, executive functions, and attention in individuals with Mild Cognitive Impairment (MCI). It includes interactive tasks such as virtual shopping, payment simulations, and recipe sequencing, along with 360-degree video sessions for attention and episodic memory training.
Usability of VR Exercises as Measured by an Adapted 8-Item System Usability Scale (SUS)
Adapted 8-Item System Usability Scale (SUS): Score Range: 0 to 100 points Interpretation: Higher scores indicate better usability.
Time frame: immediately post-intervention, within 30 minutes after the last intervention session- 8th session (day 8)
Comfort of VR Headset as Measured by an 8-Item SUS:
Adapted 8-Item VR Headset Comfort Rating: Score Range: 0 to 100 points Interpretation: Lower scores indicate better comfort (as most items measure discomfort).
Time frame: immediately post-intervention, within 30 minutes after the 8th session (day 8)
Professional´s Usability of VR Exercises as Measured by an Adapted 8-Item SUS:
Scale Title: Professional System Usability Scale (SUS) Score Range: 0 to 100 points Interpretation: Higher scores indicate a professional's perception of better system usability for patient care.
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
VR Headset Comfort Rating for Professionals as Measured by an Adapted 3-Item SUS:
Scale Title: Professional System Usability Scale (SUS) Score Range: 0 to 100 points Interpretation: Higher scores indicate better comfort and ease of use for the VR headset; lower scores indicate greater discomfort and difficulty with use. This rating is based on a professional assessment of the VR headset's weight, design, and control scheme's impact on patient comfort during use.
Time frame: immediately post-intervention, within 30 minutes after the 8th session (day 8)
Global Cognition as Measured by the Mini-Mental State Examination (MMSE)
MMSE is a 30-point questionnaire evaluating orientation, attention, recall, language, and visual construction Score Range: 0 to 30 points. Higher scores means better global cognition function
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Global Cognition as Measured by the Montreal Cognitive Assessment (MoCA)
MoCA is a 30-point screening tool for global cognitive function, assessing memory, attention, language, visuospatial skills, and executive function. Score Range: 0 to 30 points \- Higher scores means better global cognition function
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Short-Term Memory as Measured by the Digit Span Test (DST Forward Span)
Forward Digit Span measures verbal short-term memory. Score Range: 0 to 9 points \- Higher scores indicate better short-term verbal memory.
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Working Memory as Measured by the Digit Span Test (DST Backward Span)
Backward Digit Span assesses working memory and mental manipulation. Score Range: 0 to 9 points. Higher scores indicate better working memory.
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Visuospatial Attention as Measured by the Trail Making Test Part A (TMT-A)
TMT-A measures visual attention and processing speed. The outcome is time to completion measured in seconds, typically ranging from several seconds to several minutes. Lower times (faster completion) indicate better visuospatial attention.
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Executive Function as Measured by the Trail Making Test Part B (TMT-B)
TMTB: Trial Making Test B. Score Range: Time to complete the test measured in seconds, typically ranging from several seconds to several minutes. Lower times (faster completion) indicate better alternating attention.
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Processing Speed as Measured by the Symbol Digit Modalities Test (SDMT)
SDMT: Symbol Digit Modalities Test. The Symbol Digit Modalities Test (SDMT) measures processing speed, attention, and visual-motor coordination. During the test, participants are required to match abstract symbols with corresponding numbers using a key. The total raw score is calculated as the number of correct symbol-digit pairs completed within a 90-second interval. There is no fixed maximum score, as it varies based on individual performance. Higher scores indicate better processing speed and cognitive performance.
Time frame: Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Demographics Variables
Age: numeric
Time frame: Baseline
Demographics Variables
Gender: 0=female, 1=male, 3=others
Time frame: Baseline
The study included two separately recruited pilot groups of patients with mild cognitive impairment (MCI) participating in cognitive stimulation sessions at our outpatient unit. Group 1 (n = 25) was enrolled in Period 1 (Mondays and Wednesdays), and Group 2 (n = 20) in Period 2 (Tuesdays and Thursdays), each after applying inclusion criteria. Each group was independent, with no participant overlap. So the number of participants in Period 2 does not correspond to the number completing Period 1.
| Milestone | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Started | 25 |
| Completed | 23 |
| Not completed | 2 |
| Milestone | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Started | 20 |
| Completed | 17 |
| Not completed | 3 |
Adapted 8-Item System Usability Scale (SUS): Score Range: 0 to 100 points Interpretation: Higher scores indicate better usability.
| score on a scale from 0-100 | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Usability of VR Exercises as Measured by an Adapted 8-Item System Usability Scale (SUS) | 81.9 ± 14.9 |
Adapted 8-Item VR Headset Comfort Rating: Score Range: 0 to 100 points Interpretation: Lower scores indicate better comfort (as most items measure discomfort).
| score on a scale from 0-100 | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Comfort of VR Headset as Measured by an 8-Item SUS: | 86.5 ± 13.3 |
Scale Title: Professional System Usability Scale (SUS) Score Range: 0 to 100 points Interpretation: Higher scores indicate a professional's perception of better system usability for patient care.
| score on a scale from 0-100 | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Professional´s Usability of VR Exercises as Measured by an Adapted 8-Item SUS: | 85.2 ± 10.9 |
Scale Title: Professional System Usability Scale (SUS) Score Range: 0 to 100 points Interpretation: Higher scores indicate better comfort and ease of use for the VR headset; lower scores indicate greater discomfort and difficulty with use. This rating is based on a professional assessment of the VR headset's weight, design, and control scheme's impact on patient comfort during use.
| score on a scale from 0-100 | Virtual Reality Cognitive Stimulation Program |
|---|---|
| VR Headset Comfort Rating for Professionals as Measured by an Adapted 3-Item SUS: | 60.4 ± 22.9 |
MMSE is a 30-point questionnaire evaluating orientation, attention, recall, language, and visual construction Score Range: 0 to 30 points. Higher scores means better global cognition function
| score on a scale | Baseline - Virtual Reality Cognitive Stimulation Program | Post-Intervention - Virtual Reality Cognitive Stimulation Program |
|---|---|---|
| Global Cognition as Measured by the Mini-Mental State Examination (MMSE) | 26 ± 2.12 | 26.5 ± 2.3 |
MoCA is a 30-point screening tool for global cognitive function, assessing memory, attention, language, visuospatial skills, and executive function. Score Range: 0 to 30 points \- Higher scores means better global cognition function
| score on a scale | Baseline - Virtual Reality Cognitive Stimulation Program | Post-Intervention - Virtual Reality Cognitive Stimulation Program |
|---|---|---|
| Global Cognition as Measured by the Montreal Cognitive Assessment (MoCA) | 19 ± 4.19 | 20 ± 4.4 |
Forward Digit Span measures verbal short-term memory. Score Range: 0 to 9 points \- Higher scores indicate better short-term verbal memory.
| score on a scale | Baseline - Virtual Reality Cognitive Stimulation Program | Post-Intervention - Virtual Reality Cognitive Stimulation Program |
|---|---|---|
| Short-Term Memory as Measured by the Digit Span Test (DST Forward Span) | 4.5 ± 1.1 | 4.5 ± 0.96 |
Backward Digit Span assesses working memory and mental manipulation. Score Range: 0 to 9 points. Higher scores indicate better working memory.
| score on a scale | Baseline - Virtual Reality Cognitive Stimulation Program | Post-Intervention - Virtual Reality Cognitive Stimulation Program |
|---|---|---|
| Working Memory as Measured by the Digit Span Test (DST Backward Span) | 3 ± 0.97 | 3 ± 0.77 |
TMT-A measures visual attention and processing speed. The outcome is time to completion measured in seconds, typically ranging from several seconds to several minutes. Lower times (faster completion) indicate better visuospatial attention.
| seconds | Baseline - Virtual Reality Cognitive Stimulation Program | Post-Intervention - Virtual Reality Cognitive Stimulation Program |
|---|---|---|
| Visuospatial Attention as Measured by the Trail Making Test Part A (TMT-A) | 70.5 ± 50.4 | 65.5 ± 38.3 |
TMTB: Trial Making Test B. Score Range: Time to complete the test measured in seconds, typically ranging from several seconds to several minutes. Lower times (faster completion) indicate better alternating attention.
| seconds | Baseline - Virtual Reality Cognitive Stimulation Program | Post-Intervention - Virtual Reality Cognitive Stimulation Program |
|---|---|---|
| Executive Function as Measured by the Trail Making Test Part B (TMT-B) | 195.5 ± 421 | 205 ± 426 |
SDMT: Symbol Digit Modalities Test. The Symbol Digit Modalities Test (SDMT) measures processing speed, attention, and visual-motor coordination. During the test, participants are required to match abstract symbols with corresponding numbers using a key. The total raw score is calculated as the number of correct symbol-digit pairs completed within a 90-second interval. There is no fixed maximum score, as it varies based on individual performance. Higher scores indicate better processing speed and cognitive performance.
| Number of correct corresponding pairs | Baseline - Virtual Reality Cognitive Stimulation Program | Post-Intervention - Virtual Reality Cognitive Stimulation Program |
|---|---|---|
| Processing Speed as Measured by the Symbol Digit Modalities Test (SDMT) | 17 ± 9.8 | 18.5 ± 9.5 |
Age: numeric
| years | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Demographics Variables | 75.5 ± 6.19 |
Gender: 0=female, 1=male, 3=others
| Participants | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Male | 17 |
| Female | 23 |
Collected over Adverse event data were collected over a 3-month period during the pilot study.. Non-serious events are listed at a 4% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Virtual Reality Cognitive Stimulation Program | 0/45 (0%) | 0/45 (0%) | 2/45 (4.4%) |
| Event | Virtual Reality Cognitive Stimulation Program |
|---|---|
| CybersicknessEar and labyrinth disorders | 2/45 |
| Age, Continuous(years) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Median | 75 ± 5.9 |
| Sex: Female, Male(Participants) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Female | 27 |
| Male | 18 |
| Ethnicity (NIH/OMB)(Participants) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Hispanic or Latino | 44 |
| Not Hispanic or Latino | 1 |
| Unknown or Not Reported | 0 |
| Region of Enrollment(participants) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Spain | 45 |
| Global Cognition State as Measured by the MMSE(units on a score 0-30) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Median | 25.98 ± 2.02 |
| Global Cognition State as Measured by the MoCA(units on a score 0-30) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Median | 17.98 ± 4.35 |
| Short Term Verbal Memory as Measured by DST (Forward Span)(units on a score 0-9) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Median | 4 ± 1.07 |
| Working Memory as Measure by the DST (Backward Span)(units on a score 0-9) | Virtual Reality Cognitive Stimulation Program |
|---|---|
| Median | 3 ± 0.93 |
3 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Not applicable; individual participant data will not be shared.
Ran from Oct 2023 to primary completion in Feb 2024, 3 months.
Results were first posted in Mar 2025, 1 year after primary completion.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 3 months is below that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Badalona Serveis Assistencials